Cutera, Inc. Share Price

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
2.12 USD +3.92% Intraday chart for Cutera, Inc. +8.72% -39.86%
Sales 2023 212M 17B Sales 2024 * 163M 13.07B Capitalization 42.32M 3.39B
Net income 2023 -151M -12.09B Net income 2024 * -131M -10.49B EV / Sales 2023 0.33 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.26 x
P/E ratio 2023
-0.46 x
P/E ratio 2024 *
-0.39 x
Employees 540
Yield 2023 *
-
Yield 2024 *
-
Free-Float 95.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.92%
1 week+8.72%
Current month+44.22%
1 month+52.52%
3 months-27.40%
6 months-36.14%
Current year-39.86%
More quotes
1 week
1.81
Extreme 1.8107
2.25
1 month
1.28
Extreme 1.2801
2.68
Current year
1.28
Extreme 1.2801
4.97
1 year
1.28
Extreme 1.2801
23.28
3 years
1.28
Extreme 1.2801
74.38
5 years
1.28
Extreme 1.2801
74.38
10 years
1.28
Extreme 1.2801
74.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 18/05/23
Director of Finance/CFO 58 30/06/21
Chief Tech/Sci/R&D Officer 61 30/09/19
Members of the board TitleAgeSince
Director/Board Member 68 16/05/21
Director/Board Member 66 -
Chief Executive Officer 48 18/05/23
More insiders
Date Price Change Volume
26/04/24 2.12 +3.92% 703,188
25/04/24 2.04 +4.08% 383,488
24/04/24 1.96 -8.84% 332,654
23/04/24 2.15 +10.82% 801,744
22/04/24 1.94 -0.51% 535,073

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.12 USD
Average target price
6.333 USD
Spread / Average Target
+198.74%
Consensus